FRM
Fox Run Management’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-38,668
| Closed | -$788K | – | 975 |
|
|
2024
Q4 | $788K | Buy |
+38,668
| New | +$788K | 0.14% | 252 |
|
|
2024
Q3 | – | Sell |
-24,390
| Closed | -$566K | – | 866 |
|
|
2024
Q2 | $566K | Buy |
+24,390
| New | +$566K | 0.11% | 361 |
|
|
2023
Q3 | – | Sell |
-12,478
| Closed | -$368K | – | 766 |
|
|
2023
Q2 | $368K | Buy |
12,478
+3,561
| +40% | +$105K | 0.1% | 375 |
|
|
2023
Q1 | $205K | Buy |
+8,917
| New | +$205K | 0.07% | 528 |
|
|
2022
Q4 | – | Sell |
-14,977
| Closed | -$460K | – | 684 |
|
|
2022
Q3 | $460K | Buy |
+14,977
| New | +$460K | 0.18% | 199 |
|